TherapeuticsMD (TXMD) Stock Chart & Stock Price History → The #1 Crypto That You Don’t Own… Yet (From Crypto 101 Media) (Ad) Free TXMD Stock Alerts $2.22 +0.09 (+4.23%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TherapeuticsMD Stock Price Performance5 Day Performance+3.74%1 Month Performance+18.09%3 Month Performance-12.60%6 Month Performance-18.98%Year-To-Date Performance-1.33%1 Year Performance-46.51% Receive TXMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TherapeuticsMD and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyThe only financial event in 2024 that matters Man Who Predicted 2008 Crash Warns of Black Swan Financial Event in 2024 Porter Stansberry’s new documentary is going viral.Stream the documentary for free by clicking here TXMD Stock Chart for Saturday, June, 1, 2024 TXMD Chart by TradingView TherapeuticsMD Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$2.13$2.22+4.23%$2.22$2.1010,453 shs$25.60 million05/30/2024$2.18$2.13-2.29%$2.20$2.1211,265 shs$24.56 million05/29/2024$2.20$2.18-0.91%$2.19$2.095,663 shs$25.14 million05/28/2024$2.14$2.20+2.80%$2.20$2.0811,404 shs$25.37 million05/27/2024$2.14$2.14$2.14$2.088,000 shs$24.67 million05/24/2024$2.11$2.14+1.42%$2.14$2.088,087 shs$24.67 million Get the Latest News and Ratings for TXMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TherapeuticsMD and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$2.14$2.11-1.40%$2.14$2.0618,427 shs$24.33 million05/22/2024$2.09$2.14+2.39%$2.17$2.065,980 shs$24.67 million05/21/2024$2.14$2.09-2.34%$2.14$2.055,442 shs$24.10 million05/20/2024$2.22$2.14-3.60%$2.19$2.1315,524 shs$24.67 million05/17/2024$2.12$2.22+4.72%$2.25$2.0921,758 shs$25.60 million05/16/2024$2.09$2.12+1.44%$2.13$2.0519,586 shs$24.44 million05/15/2024$2.04$2.09+2.45%$2.10$2.0310,019 shs$24.10 million05/14/2024$2.08$2.04-1.92%$2.10$2.0314,056 shs$23.53 million05/13/2024$2.03$2.08+2.46%$2.08$2.0010,163 shs$23.98 million05/10/2024$2.03$2.03$2.03$2.005,325 shs$23.41 million05/09/2024$2.03$2.03$2.03$1.9913,774 shs$23.41 million05/08/2024$1.96$2.03+3.57%$2.03$1.997,063 shs$23.41 million05/07/2024$1.96$1.96$2.01$1.8916,646 shs$22.60 million05/06/2024$1.88$1.96+4.26%$1.98$1.8614,540 shs$22.60 million05/03/2024$1.87$1.88+0.53%$1.92$1.8424,551 shs$21.68 million05/02/2024$1.88$1.87-0.53%$1.92$1.877,134 shs$21.56 million05/01/2024$1.88$1.88$1.91$1.859,225 shs$21.68 million04/30/2024$1.89$1.88-0.53%$1.95$1.8515,693 shs$21.68 million04/29/2024$1.86$1.89+1.61%$1.93$1.8631,568 shs$21.80 million04/26/2024$1.87$1.88+0.53%$1.90$1.866,212 shs$21.68 million04/25/2024$1.92$1.87-2.60%$1.91$1.8710,553 shs$21.56 million04/24/2024$1.89$1.92+1.59%$1.93$1.8614,824 shs$22.14 million04/23/2024$1.86$1.89+1.61%$1.89$1.8620,700 shs$21.79 million04/22/2024$1.86$1.86$1.91$1.8618,978 shs$21.45 million04/19/2024$1.90$1.86-2.11%$1.98$1.8610,322 shs$21.45 million04/18/2024$1.89$1.90+0.53%$1.99$1.885,718 shs$21.91 million04/17/2024$1.90$1.89-0.53%$2.02$1.8829,020 shs$21.79 million04/16/2024$1.95$1.90-2.56%$2.02$1.8645,653 shs$21.91 million04/15/2024$1.99$1.95-2.01%$2.05$1.9538,121 shs$22.49 million04/12/2024$2.08$1.99-4.33%$2.08$1.9631,901 shs$22.94 million04/11/2024$2.11$2.08-1.42%$2.11$2.0528,108 shs$23.99 million04/10/2024$2.15$2.11-1.86%$2.24$2.0719,429 shs$24.79 million04/09/2024$2.16$2.15-0.46%$2.34$2.0388,545 shs$24.79 million04/08/2024$2.21$2.16-2.04%$2.24$2.1545,965 shs$24.91 million“This will be one of the biggest revolutions ever.” - NVIDIA CEO (Ad)NVIDIA's CEO calls it the "next amazing revolution"... The Economist says its a "boon to humanity"... And Jeff Bezos is heavily invested in it.A new breakthrough tech could add up to $20 trillion to the U.S. economy.04/05/2024$2.24$2.21-1.56%$2.26$2.2112,526 shs$25.42 million04/04/2024$2.23$2.24+0.67%$2.28$2.2253,821 shs$25.83 million04/03/2024$2.25$2.23-0.89%$2.27$2.2244,213 shs$25.65 million04/02/2024$2.32$2.25-3.23%$2.37$2.2412,797 shs$23.75 million04/01/2024$2.29$2.32+1.31%$2.38$2.2820,449 shs$24.55 million03/29/2024$2.29$2.29$2.31$2.2512,332 shs$24.23 million03/28/2024$2.25$2.29+1.78%$2.31$2.259,722 shs$24.23 million03/27/2024$2.25$2.25$2.30$2.2112,650 shs$23.81 million03/26/2024$2.29$2.25-1.75%$2.30$2.2412,164 shs$23.81 million03/25/2024$2.29$2.29$2.34$2.2414,688 shs$24.23 million03/22/2024$2.30$2.29-0.43%$2.39$2.2636,545 shs$24.23 million03/21/2024$2.35$2.30-2.13%$2.40$2.308,092 shs$24.33 million03/20/2024$2.29$2.35+2.62%$2.40$2.278,077 shs$24.86 million03/19/2024$2.30$2.29-0.43%$2.40$2.2520,830 shs$24.23 million03/18/2024$2.40$2.30-4.17%$2.61$2.2154,599 shs$24.33 million03/15/2024$2.36$2.40+1.69%$2.40$2.3014,438 shs$25.39 million03/14/2024$2.38$2.36-0.84%$2.43$2.3224,778 shs$24.97 million03/13/2024$2.39$2.38-0.21%$2.48$2.3414,658 shs$25.18 million03/12/2024$2.25$2.39+6.00%$2.40$2.2314,359 shs$25.23 million03/11/2024$2.33$2.25-3.43%$2.51$2.2345,408 shs$23.81 million03/08/2024$2.29$2.34+2.18%$2.44$2.2618,424 shs$24.76 million03/07/2024$2.45$2.29-6.53%$2.49$2.1437,402 shs$24.23 million03/06/2024$2.69$2.45-8.92%$2.75$2.3836,937 shs$25.92 million03/05/2024$2.64$2.69+2.09%$2.72$2.6226,253 shs$28.46 million03/04/2024$2.54$2.64+3.74%$2.66$2.5549,981 shs$27.88 million03/01/2024$2.40$2.54+5.83%$2.59$2.3972,777 shs$26.87 million02/29/2024$2.37$2.40+1.27%$2.41$2.2913,188 shs$25.39 million Related Companies: LifeVantage Stock Price Chart ProPhase Labs Stock Price Chart Assertio Stock Price Chart Tiziana Life Sciences Stock Price Chart Connect Biopharma Stock Price Chart YS Biopharma Stock Price Chart Eton Pharmaceuticals Stock Price Chart Oramed Pharmaceuticals Stock Price Chart SCYNEXIS Stock Price Chart Relmada Therapeutics Stock Price Chart Receive TXMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TherapeuticsMD and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TXMD) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TherapeuticsMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.